Christopher B Granger

Christopher B Granger

UNVERIFIED PROFILE

Are you Christopher B Granger?   Register this Author

Register author
Christopher B Granger

Christopher B Granger

Publications by authors named "Christopher B Granger"

Are you Christopher B Granger?   Register this Author

100Publications

1063Reads

8Profile Views

Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.

Clin Trials 2020 Aug 26;17(4):360-367. Epub 2020 Jun 26.

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774520928426DOI Listing
August 2020

Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey.

J Card Fail 2020 07 4;26(7):635-636. Epub 2020 Jun 4.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Duke College of Nursing, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2020.05.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272147PMC
July 2020

Extracellular vesicles in atrial fibrillation and stroke.

Thromb Res 2020 Jul 15;193:180-189. Epub 2020 Jul 15.

Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2020.07.029DOI Listing
July 2020

Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review.

JAMA Cardiol 2020 Jul 29. Epub 2020 Jul 29.

Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2020.2855DOI Listing
July 2020

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.

Circulation 2020 Apr 12;141(17):1384-1392. Epub 2020 Mar 12.

Division of Cardiology, Department of Medicine, Duke Health (S.D.P., J.H.A., C.B.G.), Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044059DOI Listing
April 2020

Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus.

Circulation 2020 Apr 13;141(15):1235-1237. Epub 2020 Apr 13.

The Stanford Center for Clinical Research, Department of Medicine, Stanford School of Medicine, Palo Alto, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.045864DOI Listing
April 2020

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.

J Am Coll Cardiol 2020 Apr;75(15):1743-1754

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.02.045DOI Listing
April 2020

Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.

J Am Coll Cardiol 2020 Mar;75(10):1145-1155

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.12.060DOI Listing
March 2020

Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.

J Am Coll Cardiol 2020 Mar;75(11):1299-1308

Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.01.019DOI Listing
March 2020

Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?

Eur Heart J 2020 Feb 7. Epub 2020 Feb 7.

Duke Clinical Research Institute, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz956DOI Listing
February 2020

Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.

J Cardiovasc Electrophysiol 2019 12 17;30(12):2968-2976. Epub 2019 Oct 17.

Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jce.14182DOI Listing
December 2019

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.

N Engl J Med 2019 11;381(20):1909-1917

From the Division of Cardiovascular Medicine (M.V.P.), Stanford Center for Clinical Research (K.W.M., A.R., N.T.), the Quantitative Sciences Unit (H.H., A.G., V.B., J.L., S.E.G., M.D.), Information Resources and Technology (T.F., G.H.), Department of Medicine (S.D.), and the Center for Digital Health (M.P.T.), Stanford University, Stanford, Apple, Cupertino (L.C., D.N., A.B., S.D.), and the Veterans Affairs Palo Alto Health Care System, Palo Alto (M.P.T.) - all in California; the University of Colorado School of Medicine, Aurora (J.S.R.); the Division of Cardiovascular Disease, Cooper Medical School of Rowan University, Camden, NJ (A.M.R.); the Lankenau Heart Institute and Jefferson Medical College, Philadelphia (P.K.); StopAfib.org, American Foundation for Women's Health, Decatur, TX (M.T.H.); and the Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1901183DOI Listing
November 2019

Continuous anticoagulation with catheter ablation: answers and questions.

Eur Heart J 2019 09;40(36):3022-3025

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz322DOI Listing
September 2019

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5).

J Am Coll Cardiol 2019 08 2;74(5):699-711. Epub 2019 Jul 2.

Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.02.080DOI Listing
August 2019

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients.

Circ Cardiovasc Qual Outcomes 2019 07 9;12(7):e005103. Epub 2019 Jul 9.

Duke Clinical Research Institute, Durham, NC (J.S.S., D.N.H., L.T., E.D.P., C.B.G., M.T.R., T.Y.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005103DOI Listing
July 2019

Authors' Reply.

J Am Soc Nephrol 2019 06 6;30(6):1137-1138. Epub 2019 May 6.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2019040353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551775PMC
June 2019

Risk of Total Events With Icosapent Ethyl: Can We Reduce It?

J Am Coll Cardiol 2019 06;73(22):2803-2805

Duke Clinical Research Institute and the Division of Cardiology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.03.492DOI Listing
June 2019

Peripheral blood metabolite profiles associated with new onset atrial fibrillation.

Am Heart J 2019 05 14;211:54-59. Epub 2019 Feb 14.

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC; Duke Clinical & Translational Science Institute, Duke University Medical Center, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117874PMC
May 2019

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

N Engl J Med 2019 05;380(20):1906-1917

From the University Duisburg-Essen and University Hospital Essen, Essen (H.-C.D.), Boehringer Ingelheim Pharma GmbH K.G., Biberach (C.G.), Boehringer Ingelheim International GmbH, Ingelheim, Faculty of Medicine Mannheim of the University of Heidelberg, Mannheim (M.B.), Kreisklinikum Siegen, Siegen, and the University of Marburg, Marburg (M.G.), University Hospital Erlangen, Erlangen (B.K.), and Johannes Wesling Klinikum Minden and Ruhr University Bochum, Minden (P.D.S.) - all in Germany; Miller School of Medicine, University of Miami, Miami (R.L.S.); University of California at San Francisco, San Francisco (J.D.E.), and the Department of Neurology and Comprehensive Stroke Center, University of California at Los Angeles, Los Angeles (J.L.S.) - both in California; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (C.B.G.); Feinberg School of Medicine of Northwestern University, Chicago (R.A.B.); International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo (S.U.), and the National Cerebral and Cardiovascular Center, Osaka (K.T.) - both in Japan; Boehringer Ingelheim, Singapore, Singapore (J. Kreuzer); Boehringer Ingelheim, Burlington, ON, Canada (L.C.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.C.); City Clinical Emergency Care Hospital, Kursk (M.C.), and the Military Medical Academy, St. Petersburg (M.O.) - both in Russia; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia (G.D.); Serviço de Neurologia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal (J.M.F.); F. Ass. Mutua Terrassa, Terrassa (J. Krupinski), and Servicio de Neurología, Hospital Universitario Ramón y Cajal (IRYCIS), Departamento de Medicina, Universidad de Alcalá, Madrid (J.M.) - both in Spain; Hallym University Sacred Heart Hospital, Seoul, South Korea (B.-C.L.); KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology, VIB Center for Brain & Disease Research, University Hospitals Leuven, Department of Neurology, Leuven, Belgium (R.L.); and Hospital Policlinico Umberto I, Sapienza University, Rome (D.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1813959DOI Listing
May 2019

Risk stratification for stroke in atrial fibrillation: a critique.

Eur Heart J 2019 04;40(16):1294-1302

Division of Heart Rhythm Services, Department of Cardiovascular Disease, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy731DOI Listing
April 2019

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

N Engl J Med 2019 04 17;380(16):1509-1524. Epub 2019 Mar 17.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., G.H., A.N.V., T.M., C.B.G., J.H.A.); Bristol-Myers Squibb, Princeton, NJ (R.A., J.L.); Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Foundation, New York (R.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton (S.G.G.), and the Terrence Donnelly Heart Centre, St. Michael's Hospital, University of Toronto, Toronto (S.G.G.) - both in Canada; Swiss Cardiovascular Center, Bern, Switzerland (S.W.); Vivantes Neukoelln Medical Center, Berlin (H.D.), and Heart Center Leipzig, Department of Internal Medicine-Cardiology, University of Leipzig, Leipzig (H.T.) - both in Germany; Pirogov Russian National Research Medical University, Moscow (O.A.); Instituto de Neurología Cognitiva (INECO) Neurociencias Oroño, Fundación INECO, Rosario, Argentina (M.C.B.); Hospital Israelita Albert Einstein, São Paulo (O.B.); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); the Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (Z.H.); the National Scientific Center, Strazhesko Institute of Cardiology, Kiev, Ukraine (A.P.); University Hospitals Leuven, University of Leuven, Leuven, Belgium (P.S.); the Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom (R.F.S.); and University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania (D.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1817083DOI Listing
April 2019

The changing epidemiology of ventricular arrhythmias and sudden cardiac death: Is it a reality?

Heart Rhythm 2019 03 4;16(3):367-368. Epub 2018 Oct 4.

Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15475271183101
Publisher Site
http://dx.doi.org/10.1016/j.hrthm.2018.09.031DOI Listing
March 2019

Understanding and Targeting Inflammation in Acute Myocardial Infarction: An Elusive Goal.

J Am Coll Cardiol 2018 07;72(2):199-201

Duke Clinical Research Institute and the Division of Cardiology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.05.006DOI Listing
July 2018